Qiagen enhances bioinformatics workflows with new secondary analysis solution for oncology

Germany-headquartered company Qiagen has announced the availability of QCI Secondary Analysis, a cloud-based software-as...

May 6, 2024 | Monday | News
Cytomos offers sneak preview of flagship technology at London Biotechnology Show 2024

TechBio company Cytomos will be giving visitors to this year’s London Biotechnology Show a sneak preview of C...

May 3, 2024 | Friday | News
Bio-Techne announces new distribution agreement with Thermo Fisher

Bio-Techne Corporation, a global life sciences company providing innovative tools and bioactive reagents for the researc...

May 2, 2024 | Thursday | News
Qiagen expands tuberculosis portfolio with new NGS Panel

Germany-headquartered firm Qiagen has announced the launch of the QIAseq xHYB Mycobacterium tuberculosis Panel for resea...

April 29, 2024 | Monday | News
Serum Institute of India partners with Univercells to make personalised cancer treatments more accessible

Serum Institute of India (SII), the world’s largest vaccine manufacturer, has joined forces with Univercells,...

April 12, 2024 | Friday | News
Global collaboration to combat chronic lung infection

Scientists have discovered a target for the development of a drug to combat a bacterium that can cause chronic lung infe...

April 10, 2024 | Wednesday | News
Ascend Advanced Therapies Acquires CMC Team and Facility in Florida from Beacon Therapeutics

 Ascend Advanced Therapies (Ascend), a total solutions gene therapy development partner, has acquired the CMC ...

April 9, 2024 | Tuesday | News
French sales subsidiary of Japanese pharma firm Eisai divests rights of neurology drugs for € 56.5 M

Japan headquartered pharma company Eisai Co. has announced that its French sales subsidiary Eisai S.A.S. has entered int...

April 9, 2024 | Tuesday | News
Japan's NS Pharma & UK-based MiNA Therapeutics lay focus on rare diseases of Central Nervous System

NS Pharma, Inc. has announced that its parent company, Nippon Shinyaku Co., headquartered in Kyoto, Japan, has ente...

April 4, 2024 | Thursday | News
Polyplus Launches Innovative Plasmid for AAV Vector Production, Strengthening Its Position in Biologic and Cell & Gene Therapy Solutions

  Polyplus (part of Sartorius, a distinguished upstream solutions provider for biologic and cell and gene the...

March 27, 2024 | Wednesday | News
Korean startup Lunit delivers AI-powered cancer screening solution to France and Portugal

Lunit, a leading provider of artificial intelligence (AI)-powered solutions for cancer diagnostics and therapeutics, has...

March 18, 2024 | Monday | News
TFS HealthScience establishes operation in Australia expanding its CRO capabilities to APAC

TFS HealthScience (TFS), a leading global Contract Research Organization (CRO), has expanded into the Asia Pacific&...

March 12, 2024 | Tuesday | News
New ‘spin freezing’ technique to enhance future mRNA vaccines

A top-ranking public research university in Belgium has received funding from Norway-based Coalition for Epidemic Prepar...

March 12, 2024 | Tuesday | News
Polyplus expands GMP offer with protein production and adds GMP capacity in Belgium

Polyplus (part of Satorius) company, Xpress Biologics, has received a good manufacturing practice (GMP) c...

March 6, 2024 | Wednesday | News
First ever large-scale GMP manufacturing of therapeutic IgE antibody achieved in the UK

Epsilogen, a leading immunoglobulin E (IgE) antibodies developer treating cancer, and global biopharma leader Lonza have...

March 5, 2024 | Tuesday | News
Medigene AG expands patent portfolio in Japan for iM-TCR Technology

Medigene AG, an immuno-oncology platform company focusing on the discovery and development of T cell immunotherapie...

March 4, 2024 | Monday | News
Japan's Daiichi Sankyo invests €1B in Germany site, expanding into innovation centre

With investments of approximately one billion euros, Japan headquartered Daiichi Sankyo will expand its production and ...

February 29, 2024 | Thursday | News
Eppendorf Innovation Company strengthens access to US startup scene

The Eppendorf Innovation Company (EpIC) – a  division of Eppendorf SE – continues to expand its interna...

February 14, 2024 | Wednesday | News